About Formosa Pharmaceuticals

Affiliates and Partners

For the purpose of broadening and strengthening our drug development capabilities, Formosa Pharmaceuticals entered a strategic alliance agreement with AimMax Therapeutics, Inc. (AimMax) in July, 2017. Through this agreement, AimMax and its seasoned professionals provide critical guidance and support to Formosa Pharmaceuticals in pre-clinical translation, clinical trial design, and strategies for global development and commercialization.

Along with global strategic partners such as Formosa Laboratories (Taiwan), Activus Pharma (Japan), AimMax Therapeutics (USA), EirGenix (Taiwan), and academic collaborators at Taipei Medical University, we are aggressively seeking additional valued partnerships to complement our existing pipeline and platform technologies.

Development Pipeline

Scroll to Top